Elcarn Injection 1 Gram (L-Carnitine)

Adult administration

1. Primary and secondary carnitine deficiency Myocardial metabolic disorder due to ischemic heart disease: angina, acute myocardial infarction Adults: Administer 2~3 grams of L-carnitine per day intramuscularly or intravenously in 2~3 divided doses. Adjust the dose appropriately according to age and symptoms. 2. Treatment of carnitine deficiency in patients with end-stage renal disease undergoing hemodialysis Initially, administer 10~20 milligrams/kilogram intravenously over 2~3 minutes at the end of each hemodialysis session. The dose may be adjusted according to the plasma L-carnitine level before hemodialysis.

This medication is an ampoule injection; care should be taken as glass fragments may mix when cutting the glass container. Extra caution is especially necessary when administering to children and the elderly. It should not be administered to patients with allergic reactions to this medication. Some patients may experience symptoms such as nausea or vomiting, changes in body odor, and gastritis. Administering this medication to patients with a history of seizures may increase the frequency or intensity of seizures. In studies involving chronic hemodialysis patients, various adverse reactions such as abdominal pain, pain, headache, infection, hypertension, and diarrhea have been reported. Oral administration may lead to allergic symptoms such as rashes, urticaria, and facial swelling. Patients with severely impaired kidney function or those receiving dialysis may risk the accumulation of toxic substances in the body if administered high doses for long periods. Patients taking warfarin should regularly check blood coagulation levels (INR) when starting or adjusting the dose of this medication. The safety of this medication during pregnancy has not been sufficiently established; it should only be used when the benefits outweigh the risks. It is uncertain whether this medication is excreted in breast milk, so careful consideration should be given when administering it during breastfeeding. No toxic reports have been noted in case of overdose; however, dialysis can be used to remove the drug if necessary.

• Transient dizziness
• vomiting
• body odor
• gastritis
• seizures
• abdominal pain
• accidental injury
• allergic reaction
• weakness
• low back pain

This medication should be stored in a tightly sealed container that blocks light, and it is safe to keep it at room temperature between 1 and 30 degrees Celsius.

Appearance

Clear liquid ranging from colorless to pale yellow in brown ampoules

Package unit

5ml/ampoule × 5